Maximilian Busch

1PUBLICATIONS
6CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 23, 2022
FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections.

Robert Meineke, Sonja Stelz, Maximilian Busch

Pageof 1

Frequent Collaborators

1 joint publications

Robert Meineke

1 joint publications

Sonja Stelz

1 joint publications

Christopher Werlein

1 joint publications

Danny Jonigk